News
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. completes study on crofelemer for cancer therapy-induced diarrhea in dogs. Results expected to complement positive outcomes. Company plans to file effectiveness study by Q2 2026 -
-
COMMUNIQUÉ DE PRESSE
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
Supira Medical announces FDA approval for SUPPORT II Pivotal Trial, advances in Cardiogenic Shock, and appointment of D. Keith Grossman to Board of Directors -
COMMUNIQUÉ DE PRESSE
Duck Creek Launches Duck Creek Reinsurance with Active Delivery to Help Insurers Simplify Program Management and Improve Financial Control
Duck Creek Technologies launches Duck Creek Reinsurance with Active Delivery, a cloud-native solution empowering insurers with real-time visibility and streamlined operations -
COMMUNIQUÉ DE PRESSE
H55 Delivers First Commercial, Certifiable Propulsion Battery Modules to BRM Aero for the Bristell B23 Energic Program
H55 delivers certifiable battery modules to BRM Aero for Bristell B23 Energic program, advancing electric propulsion in aviation. Significant step towards commercialization -
-
COMMUNIQUÉ DE PRESSE
Treon Secures €6.8 Million Investment Led by ACME Capital to Accelerate Industrial AI Innovation
Treon secures €6.8 million investment led by ACME Capital to accelerate industrial AI innovation, strengthening its position in smart industry solutions and autonomous industrial operations -
COMMUNIQUÉ DE PRESSE
CorTec Receives FDA Breakthrough Device Designation for Its Brain Interchange System in Stroke Rehabilitation — the First BCI Worldwide Designated for Stroke Motor Rehabilitation
CorTec GmbH granted FDA Breakthrough Device Designation for Brain Interchange System in Stroke Rehabilitation, marking a milestone in BCI technology development -
